Zimmer Biomet Holdings, Inc.

NYSE:ZBH Stock Report

Market Cap: US$19.8b

Zimmer Biomet Holdings Future Growth

Future criteria checks 2/6

Zimmer Biomet Holdings is forecast to grow earnings and revenue by 15.9% and 5.1% per annum respectively. EPS is expected to grow by 14.9% per annum. Return on equity is forecast to be 13.8% in 3 years.

Key information

15.9%

Earnings growth rate

14.92%

EPS growth rate

Medical Equipment earnings growth13.3%
Revenue growth rate5.1%
Future return on equity13.83%
Analyst coverage

Good

Last updated13 Oct 2025

Recent future growth updates

Recent updates

Zimmer Biomet Q3 Earnings To Highlight Innovation And Growth - Why I Think It's A Buy

Oct 12

Here's Why Zimmer Biomet Holdings (NYSE:ZBH) Can Manage Its Debt Responsibly

Jul 22
Here's Why Zimmer Biomet Holdings (NYSE:ZBH) Can Manage Its Debt Responsibly

Many Still Looking Away From Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

Jul 04
Many Still Looking Away From Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

Zimmer Biomet Holdings (NYSE:ZBH) Is Paying Out A Dividend Of $0.24

Jun 16
Zimmer Biomet Holdings (NYSE:ZBH) Is Paying Out A Dividend Of $0.24

Zimmer Biomet Holdings' (NYSE:ZBH) Dividend Will Be $0.24

Jun 02
Zimmer Biomet Holdings' (NYSE:ZBH) Dividend Will Be $0.24

Zimmer Biomet Holdings (NYSE:ZBH) Shareholders Will Want The ROCE Trajectory To Continue

May 27
Zimmer Biomet Holdings (NYSE:ZBH) Shareholders Will Want The ROCE Trajectory To Continue

Some May Be Optimistic About Zimmer Biomet Holdings' (NYSE:ZBH) Earnings

May 12
Some May Be Optimistic About Zimmer Biomet Holdings' (NYSE:ZBH) Earnings

An Intrinsic Calculation For Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Suggests It's 39% Undervalued

Apr 09
An Intrinsic Calculation For Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Suggests It's 39% Undervalued

Zimmer Biomet Holdings (NYSE:ZBH) Has Announced A Dividend Of $0.24

Mar 15
Zimmer Biomet Holdings (NYSE:ZBH) Has Announced A Dividend Of $0.24

Zimmer Biomet Holdings (NYSE:ZBH) Has Announced A Dividend Of $0.24

Mar 01
Zimmer Biomet Holdings (NYSE:ZBH) Has Announced A Dividend Of $0.24

Zimmer Biomet: Adding To The Growth Profile

Feb 07

Investors Appear Satisfied With Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Prospects

Feb 06
Investors Appear Satisfied With Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Prospects

These 4 Measures Indicate That Zimmer Biomet Holdings (NYSE:ZBH) Is Using Debt Reasonably Well

Jan 10
These 4 Measures Indicate That Zimmer Biomet Holdings (NYSE:ZBH) Is Using Debt Reasonably Well

Zimmer Biomet: Back On Offense With Strong Cash Flow Outlook

Jan 05

Zimmer Biomet Holdings (NYSE:ZBH) Is Due To Pay A Dividend Of $0.24

Dec 21
Zimmer Biomet Holdings (NYSE:ZBH) Is Due To Pay A Dividend Of $0.24

At US$108, Is It Time To Put Zimmer Biomet Holdings, Inc. (NYSE:ZBH) On Your Watch List?

Dec 08
At US$108, Is It Time To Put Zimmer Biomet Holdings, Inc. (NYSE:ZBH) On Your Watch List?

Shareholders Can Be Confident That Zimmer Biomet Holdings' (NYSE:ZBH) Earnings Are High Quality

Nov 07
Shareholders Can Be Confident That Zimmer Biomet Holdings' (NYSE:ZBH) Earnings Are High Quality

Results: Zimmer Biomet Holdings, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Nov 02
Results: Zimmer Biomet Holdings, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Zimmer Biomet: The Undervalued Titan Of Joint Replacements

Oct 02

Zimmer Biomet Stock: Don't Jump In At The 52-Week Low

Sep 19

Zimmer Biomet: Brighter Prospects In H2 2024

Jul 02

Zimmer Biomet Holdings: Moving Along

May 17

Earnings and Revenue Growth Forecasts

NYSE:ZBH - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20279,1011,3421,7262,05617
12/31/20268,6861,0141,6361,82925
12/31/20258,2188321,1001,59026
6/30/20257,8348241,1511,663N/A
3/31/20257,6999131,1311,654N/A
12/31/20247,6799049021,499N/A
9/30/20247,5961,0841,0141,582N/A
6/30/20247,5259978441,523N/A
3/31/20247,4529647591,502N/A
12/31/20237,3941,0248751,582N/A
9/30/20237,2794745481,237N/A
6/30/20237,1965067241,351N/A
3/31/20237,1084508581,355N/A
12/31/20226,9402908091,285N/A
9/30/20226,8923669701,406N/A
6/30/20226,9083349571,389N/A
3/31/20226,8893251,0781,490N/A
12/31/20216,8274451,0741,499N/A
9/30/20217,1358341,1641,559N/A
6/30/20217,3799141,1321,507N/A
3/31/20216,8425636181,000N/A
12/31/20206,128-118341,205N/A
9/30/20207,065-1527621,203N/A
6/30/20207,028378991,399N/A
3/31/20207,7913771,0081,753N/A
12/31/20197,9821,1328651,586N/A
9/30/20197,928-908301,542N/A
6/30/20197,872-3597501,448N/A
3/31/20197,891-308N/A1,541N/A
12/31/20187,933-379N/A1,747N/A
9/30/20187,9301,753N/A1,771N/A
6/30/20187,9071,690N/A1,750N/A
3/31/20187,8491,689N/A1,797N/A
12/31/20177,8031,814N/A1,582N/A
9/30/20177,748652N/A1,807N/A
6/30/20177,768712N/A1,696N/A
3/31/20177,752497N/A1,635N/A
12/31/20167,668306N/A1,632N/A
9/30/20167,604363N/A1,468N/A
6/30/20167,534227N/A1,214N/A
3/31/20166,76784N/A1,031N/A
12/31/20155,998147N/A850N/A
9/30/20155,287174N/A742N/A
6/30/20154,631325N/A899N/A
3/31/20154,646670N/A956N/A
12/31/20144,673720N/A1,061N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ZBH's forecast earnings growth (15.9% per year) is above the savings rate (3.1%).

Earnings vs Market: ZBH's earnings (15.9% per year) are forecast to grow faster than the US market (15.6% per year).

High Growth Earnings: ZBH's earnings are forecast to grow, but not significantly.

Revenue vs Market: ZBH's revenue (5.1% per year) is forecast to grow slower than the US market (10.1% per year).

High Growth Revenue: ZBH's revenue (5.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: ZBH's Return on Equity is forecast to be low in 3 years time (13.8%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/17 18:46
End of Day Share Price 2025/10/17 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Zimmer Biomet Holdings, Inc. is covered by 49 analysts. 26 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David ToungArgus Research Company
Jeffrey JohnsonBaird
Adam FeinsteinBarclays